3-cycloheptylpropanal | 22047-02-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-cycloheptylpropanal
• CAS: 22047-02-5
• 化学式: C₁₀H₁₈O
• 分子量: 154.252
• InChiKey: WWCNCLRXDKGPOS-UHFFFAOYSA-N

物化性质

• 沸点：
  232.1±9.0 °C(Predicted)
• 密度：
  0.878±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-cycloheptylpropanal 在 三乙烯二胺 、 三氟乙酸 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 1.0h， 生成 3-(2-cycloheptylethyl)isoxazolidin-5-one
  参考文献：
  名称：

  Synthesis of Unprotected Spirocyclic β-Prolines and β-Homoprolines by Rh-Catalyzed C–H Insertion

  摘要：

  A series of unprotected spirocyclic beta-prolines and beta-hornoprolines are prepared by Rh-catalyzed C-H insertion. The key intermediate, a Rh nitrenoid, is generated by the N-O bond cleavage of a substituted isoxazolidin-5-one. The reaction proceeds on a gram scale with a catalyst loading of as little as 0.1 mol %, affording spirocyclic beta-amino acids that are otherwise difficult to obtain. The building blocks prepared in this work will likely find applications in medicinal chemistry.

  DOI：

  10.1021/acs.orglett.9b03198
• 作为产物：
  描述：

  3-cycloheptylpropan-1-ol 在 二甲基亚砜 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以330 mg的产率得到3-cycloheptylpropanal
  参考文献：
  名称：

  无偏 C(sp3)−H 键的 C−H 活化：金 (I) 催化的 1-溴代炔烃环异构化**

  摘要：

  描述了严格未活化的C(sp 3 )−H 键的金催化分子内插入反应。该反应使用现成的起始材料，并受益于极其简单的反应条件。已经获得了带有 C(sp 2 )−Br 键的结构多样的支架库。此外，还公开了金催化中涉及协同插入金稳定乙烯基化的原始反应途径。

  DOI：

  10.1002/anie.202305296

文献信息

• PHARMACEUTICAL USE OF SUBSTITUTED AMIDES
  申请人：Andersen Henrik Sune

  公开号：US20090124598A1

  公开（公告）日：2009-05-14

  The use of substituted amides for modulating the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.

  描述了使用替代酰胺来调节11β-羟基类固醇脱氢酶1（11βHSD1）活性以及将这些化合物用作药物组合物的用途。还描述了一类新型的替代酰胺，它们在治疗中的应用，包含这些化合物的药物组合物，以及它们在制造药物中的应用。目前的化合物是11βHSD1活性的调节剂，更具体地是抑制剂，并且可能在治疗一系列医学疾病中有用，其中降低细胞内活性糖皮质激素浓度是可取的。
• Antibacterial, antifungal compound and its production method
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0599265A1

  公开（公告）日：1994-06-01

  A compound represented by the following formula: wherein R is an acyl group which may or not be substituted. R¹ is a hydrogen atom, C₁₋₁₀ hydrocarbon group which may or may not be substituted, or an acyl group which may or may not be substituted, R² is a straight chain or branched C₁₋₁₂ alkylene group which may or may not be substituted, A is a straight chain or branched C₁₋₁₀ alkylene group, B is O, NH or S, Q is a tertiary amino or quaternary ammonium group, a nitrogen-containing heterocyclic group which may or may not be substituted, or a nitrogen-containing heterocyclic ammonium group which may or may not be substituted, and n is an integer from 1 to 10, and the method of manufacturing this compound.

  以下化合物的化学式：其中R是一个酰基，可以是取代或非取代的。R¹是氢原子，C₁₋₁₀烃基，可以是取代或非取代的酰基，R²是直链或支链的C₁₋₁₂烷基，可以是取代或非取代的，A是直链或支链的C₁₋₁₀烷基，B是O，NH或S，Q是三级胺或季铵基，一种含氮杂环基团，可以是取代或非取代的，或者一种含氮杂环铵基团，可以是取代或非取代的，n是1到10的整数。以及制造该化合物的方法。
• POLYHYDRIC PHENOL COMPOUND AND METHOD OF PRODUCING SAME
  申请人：MITSUBISHI CHEMICAL CORPORATION

  公开号：US20190210947A1

  公开（公告）日：2019-07-11

  The present invention provides a polyhydric phenol compound which has an excellent alkali resistance and which does not cause a deterioration in color even when used as a resin raw material or a color developer. The polyhydric phenol compound includes: a bisphenol compound (A) represented by the following Formula (1) and a trisphenol compound (B) represented by the following Formula (2): [wherein R 1 represents a monovalent aliphatic hydrocarbon group having from 6 to 24 carbon atoms; each of R 2 , R 3 , R 4 , R 5 and R 6 represents a monovalent hydrocarbon group having from 1 to 15 carbon atoms; and each of a, b, c, d and e represents an integer from 0 to 4]; wherein the trisphenol compound (B) is contained in an amount, in terms of absorption intensity ratio at 254 nm, of less than 1.6% by area with respect to the amount of the bisphenol compound (A).

  本发明提供了一种聚羟基酚化合物，具有优异的耐碱性能，并且即使用作树脂原料或颜料开发剂也不会导致颜色恶化。该聚羟基酚化合物包括：由以下公式（1）表示的双酚化合物（A）和由以下公式（2）表示的三酚化合物（B）：[其中R1表示具有6至24个碳原子的单价脂肪烃基；R2、R3、R4、R5和R6中的每一个表示具有1至15个碳原子的单价烃基；a、b、c、d和e中的每一个表示0至4的整数]；其中，以吸收强度比值（在254 nm处）计算，三酚化合物（B）的含量在面积上小于双酚化合物（A）的含量的1.6％。
• Pharmaceutical use of substituted amides
  申请人：Andersen Sune Henrik

  公开号：US20060111366A1

  公开（公告）日：2006-05-25

  The use of substituted amides for modulating the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.

  本文介绍了使用取代酰胺来调节11β-羟化甾体脱氢酶1型（11βHSD1）的活性以及将这些化合物用作制药组合物的方法。还介绍了一类新型的取代酰胺，它们在治疗中的应用、包含这些化合物的制药组合物以及它们在药物制剂制造中的应用。这些化合物是11βHSD1的调节剂，更具体地说是抑制剂，可用于治疗、预防和/或预防一系列需要降低活性糖皮质激素细胞内浓度的医学疾病。
• Synthesis of R-N-methylnaltrexone
  申请人：Doshan D. Harold

  公开号：US20070099946A1

  公开（公告）日：2007-05-03

  This invention relates to stereoselective synthesis of R-MNTX and intermediates thereof, pharmaceutical preparations comprising R-MNTX or intermediates thereof and methods for their use.

  本发明涉及R-MNTX和其中间体的立体选择性合成，包括R-MNTX或其中间体的制药制剂以及使用它们的方法。